Letermovir prophylaxis reduces the risk for CMV reactivation after allogeneic stem cell transplantation

被引：0
|
作者：
Koch, K. [1 ]
Herhaus, P. [1 ]
Osswald, L. [1 ]
Braitsch, K. [1 ]
Bassermann, F. [1 ]
Verbeek, M. [1 ]
机构：
[1] Tech Univ Munich, Munich, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V639
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [21] Letermovir Prophylaxis Is Effective in Preventing CMV Reactivation and Is Associated with Decreased Non-Relapse Mortality in Two-Step Allogeneic Stem Cell Transplantation
    Tucker, Matthew J.
    Yorker, Marc
    Filicko-O'Hara, Joanne
    O'Hara, William
    Gergis, Usama
    Keiffer, Gina
    Bi, Xia
    BLOOD, 2024, 144 : 7320 - 7321
  • [22] CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
    Michele Malagola
    Vera Radici
    Mirko Farina
    Simone Pellizzeri
    Filippo Spoldi
    Enrico Morello
    Nicola Polverelli
    Eugenia Accorsi Buttini
    Simona Bernardi
    Federica Re
    Alessandro Leoni
    Liana Signorini
    Arnaldo Caruso
    Domenico Russo
    Bone Marrow Transplantation, 2024, 59 : 138 - 140
  • [23] CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
    Malagola, Michele
    Radici, Vera
    Farina, Mirko
    Pellizzeri, Simone
    Spoldi, Filippo
    Morello, Enrico
    Polverelli, Nicola
    Buttini, Eugenia Accorsi
    Bernardi, Simona
    Re, Federica
    Leoni, Alessandro
    Signorini, Liana
    Caruso, Arnaldo
    Russo, Domenico
    BONE MARROW TRANSPLANTATION, 2024, 59 (01) : 138 - 140
  • [24] Letermovir Prophylaxis For Cytomegalovirus Reactivation in Allogeneic Stem Cell Transplantation: A Multicenter Italian Real-world Experience
    Paviglianiti, Annalisa
    Pitino, Annalisa
    Carella, Angelo Michele, Jr.
    Bruno, Benedetto
    Crescimanno, Alessandra
    Federico, Vincenzo
    Picardi, Alessandra
    Tringali, Stefania
    Ingrosso, Claudia
    Carluccio, Paola
    Pastore, Domenico
    Vacca, Adriana
    Serio, Bianca
    Storti, Gabriella
    Mordini, Nicola
    Leotta, Salvatore
    Cimminiello, Michele
    Prezioso, Lucia
    Loteta, Barbara
    Ferreri, Anna
    Colasante, Fabrizia
    Merla, Emanuela
    Giaccone, Luisa
    Busca, Alessandro
    Musso, Maurizio
    Scalone, Renato
    Di Renzo, Nicola
    Marotta, Serena
    Mazza, Patrizio
    Musto, Pellegrino
    Attolico, Immacolata
    Selleri, Carmine
    Gori, Mercedes
    Tripepi, Giovanni
    Porto, Gaetana
    Martino, Massimo
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 98 - 99
  • [25] High Dose Valaciclovir As CMV Prophylaxis in Allogeneic Hematopoietic Stem Cell Recipients at High Risk of CMV Reactivation
    Douglas, Genevieve
    Yong, Michelle K.
    Tio, Shio Yen
    Chau, Maggie
    Sasadeusz, Joe
    Slavin, Monica
    Xie, Mingdi
    Ritchie, David
    Chee, Lynette C. Y.
    BLOOD, 2020, 136
  • [26] RISK FACTORS OF CMV-REACTIVATION AND THE INFLUENCE OF CMV-REACTIVATION ON RISK OF LEUKEMIA RELAPSE IN CHILDREN AND ADOLESCENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Shiriaev, S.
    Chukhlovin, A.
    Vavilov, V.
    Stancheva, N.
    Barkhatov, I.
    Zubarovskaya, L.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S463 - S463
  • [27] How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation
    Einsele, Hermann
    Ljungman, Per
    Boeckh, Michael
    BLOOD, 2020, 135 (19) : 1619 - 1629
  • [28] Efficacy of CMV prophylaxis with letermovir early after transplantation
    Satake, Atsushi
    Hotta, Masaaki
    Saito, Ryo
    Konishi, Akiko
    Yoshimura, Hideaki
    Nakanishi, Takahisa
    Fujita, Shinya
    Ito, Tomoki
    Ishii, Kazuyoshi
    Nomura, Shosaku
    BONE MARROW TRANSPLANTATION, 2019, 54 : 448 - 448
  • [29] LETERMOVIR IS SAFE AND EFFECTIVE FOR TREATMENT AND PREVENTION OF CMV REACTIVATION IN PAEDIATRIC ALLOGENEIC STEM CELL TRANSPLANT
    Lucas, Nathanael
    Forster, Abbey
    Guiver, Malcolm
    Nataraj, Ramya
    Powys, Madeleine
    Barotchi, Noor
    Mustafa, Omima
    Senthil, Srividhya
    Wynn, Robert
    BONE MARROW TRANSPLANTATION, 2024, 59 : 432 - 433
  • [30] A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
    Ljungman, Per
    Schmitt, Michael
    Marty, Francisco M.
    Maertens, Johan
    Chemaly, Roy F.
    Kartsonis, Nicholas A.
    Butterton, Joan R.
    Wan, Hong
    Teal, Valerie L.
    Sarratt, Kendra
    Murata, Yoshihiko
    Leavitt, Randi Y.
    Badshah, Cyrus
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (08) : 1525 - 1533
12345